focus -WSS

focus

author：explore 2025-09-30 05:07:26 - browse：6368

On Tuesday, Google DeepMind and Isomorphic Labs announced a significant progress update on the next iteration of AlphaFold, the deep learning model that in 2020 cracked the problem of predicting a protein’s structure from its amino acid sequence, leapfrogging other approaches in computational biology.

Now, the companies say they have developed the model to predict not just standalone protein structures, but what proteins look like in combination with several classes of molecules, including small molecules and nucleic acids — capabilities that are key for drug development.

“We really needed to make progress on protein-ligand binding and co-folding of ligands with proteins in order to help us design more effective drugs,” said Demis Hassabis, CEO of both DeepMind and Isomorphic Labs, which spun out in 2021 with the goal of applying deep learning approaches to drug discovery. The updated model can also predict protein structures after they’ve been modified. “Basically the new AlphaFold can cope with all of these different things, which is pretty amazing.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Why more medical students aren't specializing in primary care

explore

knowledge

hotspot

WSS

Unicorn down: Following layoffs, Biofourmis CEO quietly departs

Can food be medicine? And other questions about a new push

Duchenne patients, backed by ‘dark money’ group, to debate drug prices

Inside the fall of star MIT scientist David Sabatini

What do new weight loss drugs mean for bariatric surgery?

Did the public have the right to know Arthur Ashe had AIDS?

entertainment

focus

hotspot

Moonlake's readout produced a cash windfall. Risks remain

Feds fine Medicare Advantage plans for overcharging members

United colonoscopy coverage change 'may cost lives,' doctors say

Apellis safety probe of eye disease drug centers on injection needle

Medicare details structure of new drug price negotiation program

Departing Stanford president retracts two papers

In age of alternative facts, a scholarly course on calling out crap

Unicorn down: Following layoffs, Biofourmis CEO quietly departs

Apple is now the first public company to be valued at $3 trillion

When is a doctor not a doctor? Try when patients address women doctors

leisure time

When is a doctor not a doctor? Try when patients address women doctors

In science, is the line between industry and academia shifting?

Grail is spending more than ever lobbying Congress

Departing Stanford president retracts two papers

AstraZeneca bets AAV gene therapy will still deliver the goods

Appeals court upholds limits to abortion pill

explore

knowledge

hotspot

focus